Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Ensysce Biosciences (ENSC) Preferred Dividend Payments (2022 - 2024)

Historic Preferred Dividend Payments for Ensysce Biosciences (ENSC) over the last 3 years, with Q1 2024 value amounting to $290.0.

  • Ensysce Biosciences' Preferred Dividend Payments fell 9650.98% to $290.0 in Q1 2024 from the same period last year, while for Dec 2024 it was $290.0, marking a year-over-year decrease of 9775.84%. This contributed to the annual value of $290.0 for FY2024, which is 9775.84% down from last year.
  • Ensysce Biosciences' Preferred Dividend Payments amounted to $290.0 in Q1 2024, which was down 9650.98% from $899.0 recorded in Q4 2023.
  • Ensysce Biosciences' Preferred Dividend Payments' 5-year high stood at $715579.0 during Q1 2022, with a 5-year trough of $290.0 in Q1 2024.
  • For the 3-year period, Ensysce Biosciences' Preferred Dividend Payments averaged around $115803.8, with its median value being $19957.5 (2022).
  • The largest annual percentage gain for Ensysce Biosciences' Preferred Dividend Payments in the last 5 years was 9636.12% (2023), contrasted with its biggest fall of 9883.88% (2023).
  • Over the past 3 years, Ensysce Biosciences' Preferred Dividend Payments (Quarter) stood at $31606.0 in 2022, then tumbled by 97.16% to $899.0 in 2023, then tumbled by 67.74% to $290.0 in 2024.
  • Its last three reported values are $290.0 in Q1 2024, $899.0 for Q4 2023, and $3729.0 during Q2 2023.